Bronchoalveolar Lavage Neutrophils and Natural Killer Cells Provide Additional Discriminatory Information in Patients with a Sarcoidosis-Suggestive BAL Profile
Background Elevated bronchoalveolar lavage fluid (BALF) CD4/CD8 ratios are widely considered supportive of sarcoidosis; however, their diagnostic accuracy remains limited. We evaluated the diagnostic value of BALF leukocyte populations and lymphocyte subsets to improve discrimination between sarcoidosis and alternative diagnoses in patients with marked BAL lymphocytosis and elevated CD4/CD8 ratio. Methods This retrospective, single-centre study included 116 BAL samples from patients with BAL lymphocytosis ≥ 30% and CD4/CD8 ratios ≥ 4. Clinical, radiological, histopathological, and BALF flow cytometry data were reviewed. Logistic regression identified independent predictors of sarcoidosis, and ROC analysis assessed the diagnostic performance of individual and combined BALF cellular markers. Results Only 26 patients (22.4%) had sarcoidosis despite fulfilling classical BAL criteria. In multivariable analysis, younger age (OR 0.95, 95% CI 0.91–0.98; p = 0.003), lower BALF neutrophil percentage (OR 0.92, 95% CI 0.84–1.00; p = 0.050), and lower NK-cell percentage (OR 0.66, 95% CI 0.45–0.97; p = 0.034) independently predicted sarcoidosis. BALF cellular profile do not differ according to sarcoidosis stage. The predictive model incorporating age, BALF neutrophil and NK cells percentages and the CD4/CD8 ratio demonstrated significantly higher discriminative ability than the model based on CD4/CD8 alone (AUC 0.802, 95% CI 0.706–0.898 vs 0.604, 95% CI 0.48–0.73; χ 2 = 7.09, p = 0.008) Conclusions Elevated BALF lymphocytosis and high CD4/CD8 ratio are not specific to sarcoidosis. A multiparametric approach that includes age, BALF neutrophil and NK-cell percentages improves discrimination between sarcoidosis and alternative diagnoses in patients with suggestive BALF profiles, which may help prevent diagnostic misclassification and optimize clinical decision-making.
Authors
- Rosalía Laporta (ORCID: https://orcid.org/0000-0002-8326-6626)
- Pablo Tutor‐Ureta (ORCID: https://orcid.org/0000-0002-3966-9073)
- Raquel Castejón (ORCID: https://orcid.org/0000-0002-9765-0303)
- Susana Mellor‐Pita (ORCID: https://orcid.org/0000-0002-7548-8341)
- Beatriz García (ORCID: https://orcid.org/0000-0002-5235-5167)
- Silvia Rosado (ORCID: https://orcid.org/0000-0002-2097-3366)
- Cristina Martín
- Laura Rubio
Institutions
- Hospital Universitario Puerta de Hierro Majadahonda (ES)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-20
- DOI
- https://doi.org/10.21203/rs.3.rs-11552028/v1
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- preprint